These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 12501646

  • 1. [Mechanism of IGF1 receptor activation and signal transduction specificity].
    Liu BY, Wang HX.
    Sheng Li Ke Xue Jin Zhan; 1998 Jul; 29(3):249-52. PubMed ID: 12501646
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Insulin and insulin-like growth factor 1 receptors: structural and functional divergence of two evolutionary related molecules].
    Leibush BN.
    Zh Evol Biokhim Fiziol; 1998 Jul; 34(1):82-96. PubMed ID: 9720152
    [No Abstract] [Full Text] [Related]

  • 5. Insulin and IGF-1 receptor trafficking and signalling.
    Foti M, Moukil MA, Dudognon P, Carpentier JL.
    Novartis Found Symp; 2004 Jul; 262():125-41; discussion 141-7, 265-8. PubMed ID: 15562826
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Insulin, IGF-I and cancer].
    Ogawa W.
    Nihon Rinsho; 2012 Jul; 70 Suppl 5():552-5. PubMed ID: 23156457
    [No Abstract] [Full Text] [Related]

  • 9. Cross-talk between IGF-I and TGF-beta signaling pathways.
    Danielpour D, Song K.
    Cytokine Growth Factor Rev; 2006 Jul; 17(1-2):59-74. PubMed ID: 16297654
    [Abstract] [Full Text] [Related]

  • 10. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D.
    Cancer Res; 2003 Feb 01; 63(3):627-35. PubMed ID: 12566306
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Insulin receptor expression by human prostate cancers.
    Cox ME, Gleave ME, Zakikhani M, Bell RH, Piura E, Vickers E, Cunningham M, Larsson O, Fazli L, Pollak M.
    Prostate; 2009 Jan 01; 69(1):33-40. PubMed ID: 18785179
    [Abstract] [Full Text] [Related]

  • 14. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.
    Alexia C, Fallot G, Lasfer M, Schweizer-Groyer G, Groyer A.
    Biochem Pharmacol; 2004 Sep 15; 68(6):1003-15. PubMed ID: 15313394
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
    Shukla A, Grisouard J, Ehemann V, Hermani A, Enzmann H, Mayer D.
    Endocr Relat Cancer; 2009 Jun 15; 16(2):429-41. PubMed ID: 19153208
    [Abstract] [Full Text] [Related]

  • 19. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
    Sun H, Tu X, Liu M, Baserga R.
    J Cell Physiol; 2007 Sep 15; 212(3):780-6. PubMed ID: 17443674
    [Abstract] [Full Text] [Related]

  • 20. IGF-II regulates metastatic properties of choriocarcinoma cells through the activation of the insulin receptor.
    Diaz LE, Chuan YC, Lewitt M, Fernandez-Perez L, Carrasco-Rodríguez S, Sanchez-Gomez M, Flores-Morales A.
    Mol Hum Reprod; 2007 Aug 15; 13(8):567-76. PubMed ID: 17556377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.